On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA

Psychopharmacology

Volumn 162, Issue 4, 2002, Pages 448-450

  Green, A Richard ^a   McGregor, Iain S ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5,7 DIHYDROXYTRYPTAMINE; ENZYME INHIBITOR; FENCLONINE; NEUROTOXIN; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN RECEPTOR; TRYPTOPHAN HYDROXYLASE;

ANXIETY; BEHAVIOR; BIOLOGICAL MODEL; BRAIN INJURY; BRAIN LEVEL; CONCENTRATION (PARAMETERS); EMOTION; EXPERIMENTAL ANIMAL; LETTER; MAZE TEST; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT STRAIN; SOCIAL INTERACTION; TIME; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CEREBRAL CORTEX; MAZE LEARNING; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 0036038315     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1158-3     Document Type: Letter

References (21)

1. A new method for lowering plasma tryptophan concentrations: No effect on affective behavior but impaired object memory in rats
2. Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in rat
3. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat
4. Acute amino acid loads that deplete brain serotonin fail to alter behavior
5. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and the effects of chlormethiazole and dizocilpine
6. Trial 2 in the elevated plus-maze - A different form of fear
7. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity
8. Mood state and brain electric activity in Ecstasy users
9. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
10. Increased anxiety in rats after 3,4-methylenedioxymetham-phetamine (MDMA, "Ecstasy"): Association with serotonin depletion
11. Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: Relationship to behavior
12. A review of the validity and variability of the elevated plus-maze animal model of anxiety
13. 5-HT and anxiety
14. Altered neuroendocrine and behavioral responses to m-m-m-m-m-chlorophenylpiperazine in 3,4-methylene methamphetamine (MDMA) users
15. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam
16. A study of the effects of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) on the subsequent long-term behaviour of rats in the plus maze and open field
17. Recreational use of ecstasy (MDMA) is associated with increased impulsivity
18. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("Ecstasy")
19. Human psychopharmacology of Ecstasy (MDMA): A review of 15 years of empirical research
20. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users
21. Reconciling the role of central serotonin neurons in human and animal behaviour